Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

被引：7
|
作者：
Wiernik, Andres [1 ]
Sperr, Wolfgang R. [2 ]
Weisdorf, Daniel [1 ]
Valent, Peter [2 ]
Ustun, Celalettin [1 ]
机构：
[1] Univ Minnesota, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA
[2] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2013年 / 88卷 / 06期
关键词：
CHEMOTHERAPY; ADULTS; SUPERIOR; AML;
D O I：
10.1002/ajh.23440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [1] Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy A Multicenter, Prospective, Observational Study in China
    Wang, Ling
    Hu, Jiong
    Sun, Yuqian
    Huang, He
    Chen, Jing
    Li, Jianyong
    Ma, Jun
    Li, Juan
    Liang, Yingmin
    Wang, Jianmin
    Li, Yan
    Yu, Kang
    Hu, Jianda
    Jin, Jie
    Wang, Chun
    Wu, Depei
    Xiao, Yang
    Huang, Xiaojun
    MEDICINE, 2016, 95 (04)
  • [2] Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
    Lopes, Lais Moreira
    Nucci, Marcio
    Portugal, Rodrigo Doyle
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 397 - 401
  • [3] Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia
    Schlenk, Richard F.
    HAEMATOLOGICA, 2024, 109 (06) : 1629 - 1630
  • [4] Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation
    Mcclellan, Kristen
    Messina, Julia
    Saullo, Jennifer
    Huggins, Jonathan
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5351 - 5358
  • [5] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [6] The Impact of Cumulative Dose of Cytarabine Consolidation on Outcomes in Older Patients with Acute Myeloid Leukemia
    Stanko, Laura M.
    Costa, Luciano J.
    Peker, Denise
    Erba, Harry P.
    Papadantonakis, Nikolaos
    BLOOD, 2018, 132
  • [7] Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia
    Deisseroth, Albert
    Farrell, Ann
    Justice, Robert
    Kane, Robert
    Sridhara, Rajeshwari
    Chen, Huanyu
    He, Kun
    Pazdur, Richard
    BLOOD, 2010, 115 (02) : 430 - 430
  • [8] High-dose cytarabine in consolidation therapy for acute promyelocytic leukemia (APL).
    Schlenk, RF
    Fröhling, S
    del Valle, F
    Dreger, P
    Fischer, JT
    Glasmacher, A
    Götze, K
    Grimminger, W
    Haas, R
    Hahn, U
    Hartmann, F
    Koller, E
    Megentahler, HG
    Schmid, P
    Waterhouse, C
    Weber, C
    Weber, W
    Döhner, K
    Döhner, H
    BLOOD, 2000, 96 (11) : 723A - 723A
  • [9] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    Schlenk, RF
    Germing, U
    Hartmann, F
    Glasmacher, A
    Fischer, JT
    Fuentes, FDY
    Götze, K
    Pralle, H
    Nerl, C
    Salwender, H
    Grimminger, W
    Petzer, A
    Hensel, M
    Benner, A
    Zick, L
    Döhner, K
    Fröhling, S
    Döhner, H
    LEUKEMIA, 2005, 19 (06) : 978 - 983
  • [10] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    R F Schlenk
    U Germing
    F Hartmann
    A Glasmacher
    J T Fischer
    F del Valle y Fuentes
    K Götze
    H Pralle
    C Nerl
    H Salwender
    W Grimminger
    A Petzer
    M Hensel
    A Benner
    L Zick
    K Döhner
    S Fröhling
    H Döhner
    Leukemia, 2005, 19 : 978 - 983
12345